Back

Left ventricular dysfunction, pulmonary congestion, or both and cardiovascular risk after acute myocardial infarction

2 September 2024 (10:45 - 10:57)
Organised by: Logo
Congress Presentation Part of: Pharmacotherapy for worsening heart failure Acute Coronary Syndromes ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Jairo Tavares Nunes

University of Toronto, Toronto (Canada)

4 More presentations in this session

Presentation thumbnail
Diuretic therapy strategies in decompensated acute heart failure: a systematic review and network metanalysis
Doctor G. Anastasia (Genoa, IT)
Abstract Slides Video
Presentation thumbnail
Acute hemodynamic effect of oral ketones in patients with acutely decompensated heart failure and low cardiac output syndrome: a prospective randomized study.
Doctor M. Sramko (Prague, CZ)
Abstract Slides Video
Presentation thumbnail
Paracetamol and adverse cardiovascular outcomes in patients with heart failure
Doctor Q. Ren (Hong Kong, HK)
Abstract Slides
Presentation thumbnail
Acetazolamide for patients with acute decompensated heart failure: a systematic review and meta-analysis of randomised controlled trials
Doctor M. Kritya (Pune, IN)
Abstract Slides Video

Access the full session

Session thumbnail
Pharmacotherapy for worsening heart failure
Video

The Event

Event poster

ESC Congress 2024

2 September 2024 10:45 CET
You may be interested in
thumbnail
Congress Presentation
Impact of sglt2 inhibitors on cardiovascular outcomes in patients with acute myocardial infarction
thumbnail
Congress Session
Pharmacotherapy for worsening heart failure
thumbnail
Congress Presentation
Where do we stand with SGLT2i post-myocardial infarction?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources